Can Diverse Technology Spillover Enhance the Innovation Originality of Firms?Multidimensional Technology Spillover and Original Innovation Research in China's Biomedical Industry
Can Diverse Technology Spillover Enhance the Innovation Originality of Firms?Multidimensional Technology Spillover and Original Innovation Research in China's Biomedical Industry
China's biomedical industry towards original innovation is the only way to realize industrial transformation and upgrading.Taking the 2005-2020 Chinese biomedical A-share listed companies as the research sample,the high-dimensional fixed-effect panel model is used to empirically analyze the causal effect and influence path of multi-dimensional technology spillover on the original innovation of pharmaceu-tical enterprises.The study found that:intra-industry,inter-industry and localized technology spillover significantly improves the original innovation level of pharmaceutical enterprises,and the incentive effect of R & D investment is the influence path,and market competition plays a negative role in regulating it.Het-erogeneity analysis shows that multi-dimensional technology spillover has a greater positive impact on state-owned,large-scale and high-tech enterprises.The research conclusions provide a reference for en-couraging the original innovation activities of bio-pharmaceutical enterprises and boosting the innovation and upgrading of China's bio-pharmaceutical industry.
关键词
原始创新/中国生物医药产业/多维技术溢出
Key words
original innovation/China's biomedical industry/multidimensional technology spillover
万方数据